placeholder image
Y. Qu All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3. 
    Diabetes, Obesity & Metabolism. 2016
  • Reduction in short-acting insulin requirement accompanies improved glycemic control with basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes. 
    Journal of Diabetes. 2016
  • Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM. 
    Diabetes, Obesity & Metabolism. 2014
  • Lower glucose variability and hypoglycemia measured by continuous glucose monitoring with novel long-acting insulin LY2605541 versus insulin glargine. 
    Diabetes care. 2014
  • Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study. 
    Diabetes care. 2013
  • A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. 
    Diabetes care. 2012
  • Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes. 
    American Journal of Medicine. 2010
  • Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysis. 
    Current Medical Research and Opinion. 2008
    • Contact
    full name
  • Y. Qu
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration